Showing 1691-1700 of 5603 results for "".
Bringing Allergy Guidelines into the Patient Exam Room
https://reachmd.com/programs/hot-topics-in-allergy/bringing-allergy-guidelines-into-patient-exam-room/3050/For the first time in 10 years, the guidelines for allergy management have been significantly updated. With the goal of optimizing asthma control for every patient, how were the new guidelines created, and how should they be applied? Dr. Stuart Stoloff, a family practitioner from Carson City, NevadaWar on Drugs: Myths of abuse and addiction
https://reachmd.com/programs/clinicians-roundtable/war-on-drugs-myths-of-abuse-and-addiction/1681/By all accounts, Winston Churchill was an alcoholic and yet he functioned at a very high level until the end of his long life. Yet does everyone who uses a potentially addictive substance become addicted? Our guest today is Dr. Berta Madras who serves as the Deputy Director of Demand ReductioChairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
https://reachmd.com/programs/cme/chairperson-perspective-acromegaly-care-individualized-diagnosis-and-management-strategies/33027/Join us to discover the current recommendations and scientific data on the diagnosis and therapeutic management of acromegaly.Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
https://reachmd.com/programs/cme/differentiating-neuromodulation-therapies-vns-dbs-ect-tms/35793/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Emerging Directions in Menin-Directed AML Therapy
https://reachmd.com/programs/cme/emerging-directions-in-menin-directed-aml-therapy/36184/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Real-World Ready: Practical Tips for Community Oncologists
https://reachmd.com/programs/cme/real-world-ready-practical-tips-for-community-oncologists/36572/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityModern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
https://reachmd.com/programs/cme/modern-neuromodulation-vagus-nerve-stimulation-in-advancing-care-for-patients-with-drug-resistant-epilepsy-and-treatment-resistant-depression/33211/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/How can you diagnose patients with SHPT earlier in CKD and control PTH levels early in the disease course? Our experts have what you need to know!Strategies for Increasing Colorectal Cancer Screening Rates
https://reachmd.com/programs/gi-insights/strategies-for-increasing-colorectal-cancer-screening-rates/13529/Looking for ways to increase colorectal screening rates in your community? Get inspiration with these creative initiatives and ideas.Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
https://reachmd.com/programs/cme/calming-overactive-immune-response-and-reducing-inflammation-with-tyk2-inhibition-in-psoriasis/50978/Join us to learn about the emerging data with TKY2 inhibitors for treatment of psoriasis.